The Vigabatrin REMS Program is called for by the FDA to ensure notified risk-benefit decisions before launching therapy, and to make sure proper use of vigabatrin while patients are treated. When vision loss will certainly occur, it is not possible for your healthcare provider to recognize.
One of the most typical negative effects of SABRIL in children 3 to 16 years is weight gain. With extreme vision loss, you may only be able to see things directly before you (sometimes called tunnel vision"). You are at danger for vision loss with any quantity of SABRIL.
If you are pregnant or mean to obtain expecting, inform your healthcare provider. If vision screening can not be done, your doctor may continue prescribing SABRIL, however will not have the ability to watch for any type of vision loss. Your health care company might quit prescribing SABRIL for you (or your kid)if vision tests are not done regularly.